Hosomi Naohisa, Noma Takashi, Ohyama Hideo, Takahashi Tsutomu, Kohno Masakazu
Second Department of Internal Medicine, Division of Stroke and Atherosclerosis, Kagawa Medical University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.
Atherosclerosis. 2002 May;162(1):69-76. doi: 10.1016/s0021-9150(01)00683-9.
The roles of transforming growth factor (TGF)-beta 1 in vascular proliferation, atherosclerosis, and plaque still remain controversial. TGF-beta 1 has been previously reported to inhibit the proliferation and migration of vascular smooth muscle cells and endothelial cells, in vitro. On the other hand, administration or transgenic overexpression of TGF-beta 1 enhances extracellular matrix synthesis and cellular hyperplasia of the intima and media in the normal artery and injured artery in vivo. We evaluated the correlation of arterial proliferation with plasma levels of TGF-beta 1 and TGF-beta receptor type II, respectively, in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a new strain of spontaneous non-insulin-dependent diabetes mellitus (NIDDM) models. OLETF rats (n=30) were divided into three groups aged 5,15, and 30 weeks. Long-Evans Tokushima Otsuka (LETO) rats (n=30) were used as age-matched non-diabetic controls. Plasma TGF-beta1 and insulin were determined by enzyme-linked immunosorbent assay. Immunoreactive TGF-beta receptor type II antigen was detected by immunohistochemistry on the thoracic artery. Arterial media area was measured microscopically. Oral glucose tolerance test was performed to examine the stage of diabetes mellitus. The thoracic aorta wall section area increased significantly from the age of 15 weeks in OLETF rats, versus LETO rats. In both OLETF and LETO rats, plasma TGF-beta 1 increased significantly from the age of 15 weeks. In OLETF rats, plasma TGF-beta 1 increased significantly over that in LETO rats (P<0.001). Furthermore, TGF-beta receptor type II was detected on aortic wall as strong signals in OLETF rats, but only weakly in LETO rats. OLETF rats showed hyperinsulinemia and insulin resistance from the age of 15 weeks. With oral glucose tolerance test, from the age of 15 weeks, the high glucose level in OLETF rats was prolonged to 2 h after loading, and the insulin levels at both fasting and after loading were significantly higher than those of LETO rats (P<0.001). There are significant linear relations between plasma TGF-beta 1 antigen and aorta wall section area, and plasma TGF-beta 1 antigen and fasting insulin level (P<0.001, respectively). We found that plasma TGF-beta 1 and vascular TGF-beta type II receptors existed to a greater extent in pre- and early stages of diabetes mellitus (DM) in OLETF rats compared with LETO rats. The greater extent of each in OLETF rats was associated with hyperinsulinemia and/or vascular thickening.
转化生长因子(TGF)-β1在血管增殖、动脉粥样硬化及斑块形成中的作用仍存在争议。此前有报道称,TGF-β1在体外可抑制血管平滑肌细胞和内皮细胞的增殖与迁移。另一方面,在体内,给予TGF-β1或通过转基因使其过表达,可增强正常动脉和损伤动脉内膜及中膜的细胞外基质合成和细胞增生。我们分别评估了大冢长-艾氏-德岛肥胖(OLETF)大鼠(一种新型自发性非胰岛素依赖型糖尿病(NIDDM)模型)中动脉增殖与血浆TGF-β1水平及II型TGF-β受体之间的相关性。将30只OLETF大鼠分为5周龄、15周龄和30周龄三组。选用30只年龄匹配的长-艾氏-德岛大冢(LETO)大鼠作为非糖尿病对照。采用酶联免疫吸附测定法测定血浆TGF-β1和胰岛素水平。通过免疫组化法检测胸主动脉中II型TGF-β受体免疫反应性抗原。在显微镜下测量动脉中膜面积。进行口服葡萄糖耐量试验以检查糖尿病阶段。与LETO大鼠相比,OLETF大鼠胸主动脉壁横截面积从15周龄起显著增加。在OLETF大鼠和LETO大鼠中,血浆TGF-β1从15周龄起均显著升高。在OLETF大鼠中,血浆TGF-β1升高幅度显著高于LETO大鼠(P<0.001)。此外,在OLETF大鼠的主动脉壁上检测到II型TGF-β受体呈强信号,而在LETO大鼠中仅呈弱信号。OLETF大鼠从15周龄起出现高胰岛素血症和胰岛素抵抗。口服葡萄糖耐量试验显示,从15周龄起,OLETF大鼠的高血糖水平在负荷后持续2小时,空腹及负荷后胰岛素水平均显著高于LETO大鼠(P<0.001)。血浆TGF-β1抗原与主动脉壁横截面积之间以及血浆TGF-β1抗原与空腹胰岛素水平之间存在显著的线性关系(分别为P<0.001)。我们发现,与LETO大鼠相比,OLETF大鼠在糖尿病前期和早期阶段血浆TGF-β1和血管II型TGF-β受体的存在程度更高。OLETF大鼠中各指标的较高水平与高胰岛素血症和/或血管增厚有关。